Exchange: NASDAQ·Updated 05:48 AM EDT
CODX logo

CODX Co-Diagnostics Inc

$1.10
$0.00
(0.00%)
Pre-Market
Prev Close $1.10
EarningsNov 16
Mkt Cap$7.71M
Vol23,102.00

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
42

Bearish Sentiment

How do you feel about CODX?

Advertisement|Remove ads.